Company intelligence / Profile preview

Hermes Pardini

Belo Horizonte, Minas Gerais, Brazilhermespardini.com.br ↗

Ownership: Private
Employees: ~7500
Development stage: Commercial

Overview

Hermes Pardini operates a large network of medical laboratories in Brazil, providing clinical diagnostics, imaging, vaccination services, DNA screening tests, toxicological exams, cardiometabolic exams and more. The company has implemented advanced laboratory automation to improve efficiency and turnaround times. It was acquired by Fleury S.A. in April 2023 for BRL 2.4 billion.

Industry: Molecular Diagnostics

Partnerships

Siemens Healthineers

Beyond the preview

Go deeper on Hermes Pardini.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hermes Pardini.

Explore the full profile